🇺🇸 FDA
Patent

US 9409956

Salmonella typhi Ty21a expressing Yersinia pestis F1-V fusion protein and uses thereof

granted A61KA61K2039/523A61K39/00

Quick answer

US patent 9409956 (Salmonella typhi Ty21a expressing Yersinia pestis F1-V fusion protein and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/523, A61K39/00, A61K39/0291, A61P